Get the Stockscreener App
76.37
4.54%
-3.7708
Inspire Medical Systems Inc stock is traded at $76.37, with a volume of 447.45K.
It is down -4.54% in the last 24 hours and down -2.88% over the past month.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
See More
Previous Close:
$80.14
Open:
$80.2
24h Volume:
447.45K
Relative Volume:
0.40
Market Cap:
$2.26B
Revenue:
$802.80M
Net Income/Loss:
$53.51M
P/E Ratio:
44.14
EPS:
1.73
Net Cash Flow:
$91.12M
1W Performance:
-0.10%
1M Performance:
-2.88%
6M Performance:
-47.09%
1Y Performance:
-62.76%
1-Day Range:
$75.80
$80.97
1-Week Range:
$75.80
$82.40
52-Week Range:
$70.77
$216.01
Inspire Medical Systems Inc Stock (INSP) Company Profile
Name
Inspire Medical Systems Inc
Sector
Industry
Phone
763-957-5037
Address
5500 WAYZATA BLVD, GOLDEN VALLEY
Compare INSP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INSP
Inspire Medical Systems Inc
|
76.38 | 2.37B | 802.80M | 53.51M | 91.12M | 1.73 |
|
ABT
Abbott Laboratories
|
132.90 | 232.02B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
96.03 | 144.14B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
368.52 | 141.53B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.95 | 123.78B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
74.33 | 44.14B | 5.69B | 1.41B | 577.90M | 6.9828 |
Inspire Medical Systems Inc Stock (INSP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-22-25 | Downgrade | UBS | Buy → Neutral |
| Sep-02-25 | Initiated | Evercore ISI | Outperform |
| Aug-05-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-05-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Aug-05-25 | Downgrade | Truist | Buy → Hold |
| Nov-20-24 | Upgrade | BofA Securities | Neutral → Buy |
| May-08-24 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-19-24 | Initiated | RBC Capital Mkts | Outperform |
| Mar-19-24 | Initiated | Morgan Stanley | Overweight |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Overweight |
| Jan-19-24 | Initiated | Jefferies | Buy |
| Jan-02-24 | Downgrade | Stifel | Buy → Hold |
| Dec-13-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Apr-14-23 | Initiated | Mizuho | Buy |
| Mar-29-23 | Initiated | UBS | Buy |
| Dec-13-22 | Upgrade | Goldman | Neutral → Buy |
| Dec-13-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Apr-13-22 | Initiated | Truist | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-04-21 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-15-20 | Downgrade | Goldman | Buy → Neutral |
| Nov-03-20 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-03-20 | Upgrade | Oppenheimer | Underperform → Perform |
| Sep-22-20 | Initiated | JP Morgan | Overweight |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Aug-06-20 | Downgrade | BofA Securities | Buy → Neutral |
| Jul-15-20 | Initiated | Goldman | Buy |
| Jun-18-20 | Reiterated | Piper Sandler | Overweight |
| May-18-20 | Initiated | Lake Street | Buy |
| Apr-28-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Apr-09-20 | Initiated | Piper Sandler | Overweight |
| Jan-28-20 | Initiated | Oppenheimer | Underperform |
| Jan-27-20 | Initiated | Oppenheimer | Underperform |
| Nov-06-19 | Upgrade | Berenberg | Sell → Hold |
| Feb-05-19 | Initiated | Dougherty & Company | Buy |
| Nov-28-18 | Initiated | Berenberg | Sell |
| Oct-29-18 | Initiated | Leerink Partners | Outperform |
| May-29-18 | Initiated | Guggenheim | Buy |
| May-29-18 | Initiated | Stifel | Buy |
| May-29-18 | Initiated | Wells Fargo | Outperform |
View All
Inspire Medical Systems Inc Stock (INSP) Latest News
Inspire Medical reports positive Inspire V therapy results - MassDevice
Inspire Medical (INSP) Reveals Promising Inspire V Clinical Outc - GuruFocus
Inspire Medical reports positive outcomes for new sleep apnea system - Investing.com
RBC Cuts Price Target on Inspire Medical Systems to $150 From $180, Keeps Outperform Rating - MarketScreener
Inspire Medical Systems Publishes Preliminary Clinical Outcomes Data for Inspire V System at AAO-HNS and ISSS Meetings - Quiver Quantitative
Inspire Medical Systems, Inc. Publishes Inspire V Data at ISSS/AAO-HNS Meetings - GlobeNewswire
Inspire Medical Systems Publishes Inspire V Data at ISSS/AAO-HNS Meetings - TradingView
Will Inspire Medical Systems Inc. price bounce be sustainable2025 Market Trends & Weekly Consistent Profit Watchlists - newser.com
What’s next for Inspire Medical Systems Inc. stock priceMarket Sentiment Summary & Daily Profit Focused Screening - newser.com
Why Inspire Medical Systems Inc. (2DR) stock could be next leaderQuarterly Portfolio Review & Safe Swing Trade Setups - newser.com
Is Inspire Medical Systems Inc. stock dividend growth reliableJuly 2025 Pullbacks & Weekly High Return Opportunities - newser.com
Jim Cramer on Inspire Medical: “They’ve Had One Execution Issue After Another” - Yahoo Finance
Calyxo Expands Board of Directors as Number of Patients Treated with its CVAC System Crosses 20000 Milestone - MarketScreener
Calyxo Expands Board of Directors as Number of Patients Treated with its CVAC System Crosses 20,000 Milestone - MarketScreener
Earnings visualization tools for Inspire Medical Systems Inc.Earnings Recap Summary & Consistent Income Trade Ideas - newser.com
Inspire Medical Systems' (INSP) Sell (D) Rating Reiterated at Weiss Ratings - MarketBeat
Inspire Medical Systems Insiders Sell US$1.3m Of Stock, Possibly Signalling Caution - 富途牛牛
Inspire Medical Systems (INSP) Sees Target Price Reduction by Ev - GuruFocus
Inspire Medical Systems (NYSE:INSP) Price Target Cut to $125.00 by Analysts at Evercore ISI - MarketBeat
Inspire Medical Systems (INSP): Valuation Perspectives After Surprise Guidance Cut and Legal Scrutiny - Yahoo Finance
Inspire Medical Systems, Inc. to Report Third Quarter 2025 Financial Results on November 3, 2025 - Sahm
How Investors May Respond To Inspire Medical Systems (INSP) Cut in Full-Year Outlook Amid Legal Probe - Yahoo Finance
Signal strength of Inspire Medical Systems Inc. stock in tech scannersTrade Performance Summary & AI Enhanced Trading Alerts - newser.com
Q3 2025 Results — Inspire Medical Systems to Report Nov 3; Webcast and Call Planned - Stock Titan
Risk vs reward if holding onto Inspire Medical Systems Inc.Portfolio Value Summary & AI Based Buy/Sell Signal Reports - newser.com
How institutional ownership impacts Inspire Medical Systems Inc. stockWeekly Stock Report & Step-by-Step Swing Trade Plans - newser.com
Is Inspire Medical Systems Inc. showing signs of accumulationWeekly Stock Analysis & Daily Entry Point Trade Alerts - newser.com
Can Inspire Medical Systems Inc. stock surprise with quarterly resultsBuy Signal & High Accuracy Buy Signal Tips - newser.com
Does Inspire Medical Systems Inc. qualify in momentum factor screeningJuly 2025 Institutional & Intraday High Probability Alerts - newser.com
Can Inspire Medical Systems Inc. stock hit record highs againBull Run & Target Return Focused Stock Picks - newser.com
Should Inspire Medical Systems’ (INSP) Accelerating Center Expansion and Cash Flow Momentum Prompt Investor Action? - Sahm
Using data tools to time your Inspire Medical Systems Inc. exitGap Down & Weekly Watchlist for Hot Stocks - newser.com
Inspire Medical Systems Hits New 52-Week Low at $72.75 - Markets Mojo
INSPIRE MEDICAL (INSP) ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
How sustainable is Inspire Medical Systems Inc. stock dividend payoutMarket Rally & Verified Short-Term Plans - newser.com
Will Inspire Medical Systems Inc. stock maintain growth storyPortfolio Profit Report & Daily Oversold Bounce Ideas - newser.com
Inspire Medical Systems (INSP): Evaluating Valuation as U.S. Expansion and Earnings Growth Draw Investor Focus - Sahm
1 Small-Cap Stock for Long-Term Investors and 2 We Brush Off - The Globe and Mail
Inspire Medical Systems Hits New 52-Week Low at $70.90 - Markets Mojo
Nyxoah Expands in the Middle East to Provide Wider Access to Genio - Yahoo Finance
Inspire Medical Systems Inc Stock (INSP) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):